What is the appropriate omeprazole dose for a pediatric patient with a gastric or duodenal ulcer, including weight‑based dosing and age considerations?

Omeprazole Dosing for Pediatric Gastric or Duodenal Ulcer

For pediatric patients with gastric or duodenal ulcers, use omeprazole 20 mg once daily for children weighing ≥20 kg and 10 mg once daily for children weighing 10 to <20 kg, administered for 4-8 weeks. 1

Weight-Based Dosing Algorithm

The FDA-approved dosing for pediatric patients ages 2-16 years is straightforward and weight-stratified 1:

• Children 10 to <20 kg: 10 mg once daily
• Children ≥20 kg: 20 mg once daily

This translates to approximately 0.5-1 mg/kg/day for most children in this weight range.

Treatment Duration

• Initial treatment: 4-8 weeks 1
• If ulcer does not heal after 8 weeks, consider an additional 4 weeks of therapy 1
• Most duodenal ulcers heal within 4 weeks; some require up to 8 weeks 1

Age Considerations

FDA approval: Omeprazole is approved for children ages 2-16 years for treatment of erosive esophagitis and symptomatic GERD 1. While not specifically FDA-approved for peptic ulcer disease in this age group, the same weight-based dosing applies based on the mechanism of acid suppression.

Children <2 years: The FDA label does not provide specific dosing for ulcer disease in this age group. Research suggests doses of 0.7-1.4 mg/kg/day may be effective 2, but this is off-label use requiring careful monitoring.

Administration Details

• Timing: Give before meals 1
• Capsule administration: Swallow whole if possible 1
• For patients unable to swallow: Open capsule and sprinkle contents on 1 tablespoon of applesauce; swallow immediately without chewing the pellets 1
• Do not crush or chew the enteric-coated pellets 1

Special Considerations for Helicobacter pylori-Associated Ulcers

If treating H. pylori-associated duodenal ulcer, use combination therapy 1:

Triple therapy:

• Omeprazole 20 mg twice daily
• Amoxicillin 1000 mg twice daily
• Clarithromycin 500 mg twice daily
• Duration: 10 days
• Follow with omeprazole 20 mg once daily for additional 18 days if ulcer present at initiation 1

Note: These are adult doses; pediatric H. pylori regimens require weight-based antibiotic dosing adjustments.

Clinical Pearls

Dosing range in literature: While the FDA label specifies fixed doses by weight category, pediatric gastroenterology literature demonstrates an effective range of 0.7-3.3 mg/kg/day 3. The lower end of this range (0.7-1 mg/kg/day) is typically sufficient for most patients 4, 5.

Response monitoring: Most patients with peptic ulcer disease respond within 2-4 weeks 4. If no improvement occurs by 4 weeks, consider endoscopic evaluation rather than simply increasing the dose.

Refractory cases: A small subset may require higher doses (up to 1.6 mg/kg/day or 40 mg/day) 4, but this should be guided by clinical response and ideally pH monitoring in complex cases.

Important Caveats

• Avoid overuse: PPIs carry risks including increased respiratory infections, gastroenteritis, and potential effects on bone health with long-term use 3
• Gastrin elevation: Expect elevated fasting gastrin levels (up to 3-5.5 times normal) with chronic use 5; clinical significance in children remains unclear
• Hepatic impairment: Dose reduction not specified in pediatric patients, but monitor liver function 1
• Drug interactions: Omeprazole inhibits CYP2C19 and can interact with clopidogrel, certain antiretrovirals, and other medications 1